Last reviewed · How we verify
Adductor Canal Block
At a glance
| Generic name | Adductor Canal Block |
|---|---|
| Also known as | Bupivacaine, ropivacaine with epinephrine, Saphenous nerve block |
| Sponsor | Kafrelsheikh University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- From Battlefield to Recovery: Continuous Regional Anaesthesia for War-Related Lower Limb Trauma
- Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty (PHASE4)
- Postoperative Analgesic Benefit of iPACK Block in the Anterior Cruciate Ligament Reconstruction Surgery (NA)
- SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty (NA)
- Peripheral Nerve Blocks and Postoperative Pain and Mobilization After Total Knee Arthroplasty
- Targeted Nerve Injection to the Knee (Nerve to Vastus Medialis): Comparing Two Adductor Canal Block Approaches (PHASE4)
- Comparison of the Postoperative Analgesic Efficacy of Infiltration Between the Popliteal Artery and the Capsule of the Knee (iPACK) Block and the Biceps Femoris Short Head Plane (BiFeS) Block in Total Knee Arthroplasty (NA)
- Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adductor Canal Block CI brief — competitive landscape report
- Adductor Canal Block updates RSS · CI watch RSS
- Kafrelsheikh University portfolio CI